Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China

A Modified Haploidentical Nonmyeloablative Transplantation without T Cell Depletion for High-Risk Acute Leukemia: Successful Engraftment and Mild GVHD

(2009) Mei Guo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-Identical Sibling Compared With 8/8 Matched and Mismatched Unrelated Donor Bone Marrow Transplant for Chronic Phase Chronic Myeloid Leukemia

(2009) Mukta Arora et al.   JOURNAL OF CLINICAL ONCOLOGY

Graft-versus-host disease

(2009) James LM Ferrara et al.   LANCET

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation

(2008) O. Ringden et al.   BLOOD

Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study

(2008) M Schleuning et al.   BONE MARROW TRANSPLANTATION

Allogeneic stem cell transplantation for chronic myeloid leukemia–status in 2007

(2008) J M Goldman   BONE MARROW TRANSPLANTATION

Combination of CsA, MTX and low-dose, short-course mycophenolate mofetil for GVHD prophylaxis

(2008) Y Lai et al.   BONE MARROW TRANSPLANTATION